Skip to content
Sexuality – Lifestyle
Author:
Cytospire
Cytospire Therapeutics Appoints Dr. Sumeet Ambarkhane as Chief Medical Officer
September 8, 2026
Cytospire Therapeutics Appoints Samit Hirawat, M.D., as Non-Executive Director
June 10, 2026
Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer
May 5, 2026